Officer / Executive – FSSC (P2P Executive Maker, India)

1 - 3 Years
Mumbai

Job Description

Job Description -
1. Perform invoice processing for assigned category of invoices.
2. Facilitate payments as per the due date of invoices.
3. Process vendor advances.
4. Handle vendor queries.
5. Process employee reimbursements.
6. Perform period end close activities related to P2P tower.
7. Ensure that individual SLAs and KPI targets are met.
8. Respond to both internal and external audit queries to ensure complete, timely and accurate responses
to information requests.
9. Add to the knowledge management databases, particularly regarding resolution of issues.
10. Perform any other ad-hoc activities assigned by Team Lead.

Job Location - Airoli

Must Have :
Total experience of 1 - 3 years in the Finance function
Good working knowledge of SAP
Good understanding of P2P process
Open to work in the Morning shift

Good to Have:
Previous work experience in the pharmaceutical sector

Salary: Not Disclosed by Recruiter

Industry:Pharma / Biotech / Clinical Research

Functional Area:Accounts, Finance, Tax, Company Secretary, Audit

Role Category:Accounts

Role:Financial Accountant

Employment Type:Permanent Job, Full Time

Keyskills

Desired Candidate Profile

Please refer to the Job description above

Education-

UG:B.Com - Commerce

PG:M.Com - Commerce

Company Profile

LUPIN LIMITED

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally. .

Lupin is the 8th largest generics pharmaceutical company in terms of market capitalization (28th December 2018, Bloomberg) and the 8th largest generics pharmaceutical company in terms of revenues (30th September 2018, Bloomberg LTM) globally.

The Company is the 3rd largest pharmaceutical player in the US by prescriptions for the Total Market (IQVIA MAT December 2018); 3rd largest Indian pharmaceutical company by global revenues (30th September 2018, Bloomberg LTM); 6th largest generic pharmaceutical player in Japan (IQVIA MAT December 2018) and 5th largest company in the Indian Pharmaceutical Market (IQVIA MAT December 2018).

For the financial year ended 31st March, 2018, Lupin’s Consolidated sales and Net profits before exceptional items were at Rs. 155,598 million (USD 2.41 billion) and Rs. 13,934 million (USD 216 million) respectively. Please visit http://www.lupin.com for more information. You could also follow us on Twitter – www.twitter.com/lupinglobal
View Contact Details+

Contact Company:LUPIN LIMITED